These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7037013)

  • 1. A comparison of the bactericidal activity of a series of rifampicins against Mycobacterium leprae.
    Pattyn SR
    Arzneimittelforschung; 1982; 32(1):15-7. PubMed ID: 7037013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivariate analysis of the activity of rifamycins against rapidly growing Mycobacteria, to define an in vitro screening model for their activity against mycobacterium leprae.
    Pattyn SR; Hébrant F
    Arzneimittelforschung; 1980; 30(12):2099-103. PubMed ID: 7011330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vitro activities of rifamycin analogues against Mycobacterium leprae.
    Dhople AM
    Indian J Lepr; 1997; 69(4):377-84. PubMed ID: 9474513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimycobacterial activities of two newer ansamycins, R-76-1 and DL 473.
    Ji BH; Chen JK; Lu XZ; Wang SY; Ni GX; Hou YH; Zhou DH; Tang QK
    Int J Lepr Other Mycobact Dis; 1986 Dec; 54(4):563-77. PubMed ID: 3546547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of a new rifamycin derivative against Mycobacterium leprae.
    Dhople AM; Dimova V
    Arzneimittelforschung; 1996 Feb; 46(2):210-2. PubMed ID: 8720317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An in vitro culture method for screening new drugs against Mycobacterium leprae.
    Dhople AM; Ortega I
    Indian J Lepr; 1990; 62(1):66-75. PubMed ID: 2193063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative bactericidal action of rifampicin alone on M. tuberculosis and M. leprae].
    Guelpa-Lauras CC; Grosset J; Truffot-Pernot C; Giroir AM
    Acta Leprol; 1982; (86-87):69-75. PubMed ID: 6815999
    [No Abstract]   [Full Text] [Related]  

  • 8. Clarithromycin is bactericidal against strains of Mycobacterium leprae resistant and susceptible to dapsone and rifampin.
    Walker LL; Van Landingham RM; Shinnick TM
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):59-65. PubMed ID: 8326182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro synergistic activity between ofloxacin and ansamycins against Mycobacterium leprae.
    Dhople AM; Ibanez MA; Gardner GD
    Arzneimittelforschung; 1993 Mar; 43(3):384-6. PubMed ID: 8387790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bactericidal action at low doses of a new rifamycin derivative, 3'-hydroxy-5'-(4-isobutyl-1-piperazinyl) benzoxazinorifamycin (KRM-1648) on Mycobacterium leprae inoculated into footpads of nude mice.
    Gidoh M; Tsutsumi S; Yamane T; Yamashita K; Hosoe K; Hidaka T
    Lepr Rev; 1992 Dec; 63(4):319-28. PubMed ID: 1479871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of two doses of rifampin against Mycobacterium leprae.
    Husser JA; Traore I; Daumerie D
    Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):359-64. PubMed ID: 7963907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The activity of several newer antimicrobials against logarithmically multiplying M. leprae in mice.
    Burgos J; de la Cruz E; Paredes R; Andaya CR; Gelber RH
    Lepr Rev; 2011 Sep; 82(3):253-8. PubMed ID: 22125933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo activities of novel benzoxazinorifamycins against Mycobacterium leprae.
    Dhople AM; Ibanez MA
    Indian J Lepr; 1995; 67(4):375-82. PubMed ID: 8849914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimum inhibitory and bactericidal dosages of rifampici against Mycobacterium leprae in the mouse foot pad: relationship to serum rifampicin concentrations.
    Holmes IB
    Int J Lepr Other Mycobact Dis; 1974; 42(3):289-96. PubMed ID: 4617716
    [No Abstract]   [Full Text] [Related]  

  • 15. The bactericidal effect of rifampicin on M. leprae in man: a) single doses of 600, 900 and 1200 mg; and b) daily doses of 300 mg.
    Levy L; Shepard CC; Fasal P
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):183-7. PubMed ID: 776856
    [No Abstract]   [Full Text] [Related]  

  • 16. The "proportional bactericidal test": a method for assessing bactericidal activity in drugs against Mycobacterium leprae in mice.
    Colston MJ; Hilson GR; Banerjee DK
    Lepr Rev; 1978 Mar; 49(1):7-15. PubMed ID: 347206
    [No Abstract]   [Full Text] [Related]  

  • 17. Bacterial growth kinetics of "M. lufu" in the presence and absence of various drugs alone and in combination. A model for the development of combined chemotherapy against M. leprae?
    Seydel JK; Wempe EG
    Int J Lepr Other Mycobact Dis; 1982 Mar; 50(1):20-30. PubMed ID: 7042611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further studies of the killing of M. leprae by aminoglycosides: reduced dosage and frequency of administration.
    Gelber RH
    Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):78-82. PubMed ID: 3549941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on short-term clinical trial of R-77-3 [3-(4-cyclo-pentyl-l-piperazinyl) imino methyl rifamycin SV] by mouse foot-pad technique].
    Wang HY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Oct; 10(5):374-5. PubMed ID: 2978259
    [No Abstract]   [Full Text] [Related]  

  • 20. The killing of Mycobacterium leprae in mice by various dietary concentrations of dapsone and rifampicin.
    Gelber RH
    Lepr Rev; 1986 Dec; 57(4):347-53. PubMed ID: 3540497
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.